TARDBP and amyotrophic lateral sclerosis: Another key aspect of this model is its ability to replicate the timeline of development of TDP-43 pathology, neuromuscular junction denervation, and spinal cord and cortical motor neuron loss, resembling the progression of ALS in humans (Walker et al., 2015).